No Data
U.S. Equity Sentiment Turns Lower in Possible Bullish Signal: Goldman Sachs
Jefferies Maintains Edwards Lifesciences(EW.US) With Hold Rating, Raises Target Price to $71
Piper Sandler Maintains Edwards Lifesciences(EW.US) With Hold Rating, Maintains Target Price $73
Wells Fargo Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $80
TD Cowen Maintains Edwards Lifesciences(EW.US) With Hold Rating, Maintains Target Price $75
Edwards Lifesciences' Growth Potential Boosted by Favorable NCD and Strategic Initiatives
